{
    "Trade/Device Name(s)": [
        "ScanScope\u00ae XT System",
        "ScanScope\u2122M XT System",
        "ScanScope\u00ae System"
    ],
    "Submitter Information": "Aperio Technologies, Inc.",
    "510(k) Number": "K080564",
    "Predicate Device Reference 510(k) Number(s)": [
        "K032113",
        "K031715"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NOT"
    ],
    "Summary Letter Date": "July 14, 2009",
    "Summary Letter Received Date": "July 16, 2009",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 864.1860"
    ],
    "Regulation Name(s)": [
        "Immunohistochemistry reagents and kits"
    ],
    "Analyte Class(es)": [
        "anatomic pathology",
        "immunology",
        "cancer molecular"
    ],
    "Analyte(s)": [
        "HER2/neu (c-erbB-2)"
    ],
    "Specimen Type(s)": [
        "Formalin-fixed, paraffin-embedded normal and neoplastic tissue"
    ],
    "Specimen Container(s)": [
        "Glass microscope slide"
    ],
    "Instrument(s)/Platform(s)": [
        "ScanScope\u00ae XT digital slide scanner",
        "Computer executing Spectrum\u2122 software"
    ],
    "Method(s)/Technology(ies)": [
        "Automated digital slide scanning",
        "Image analysis",
        "Colorimetric pattern recognition"
    ],
    "Methodologies": [
        "Immunohistochemical staining",
        "Digital image analysis",
        "Computer-assisted measurement"
    ],
    "Submission Type(s)": [
        "System",
        "Accessory",
        "Analyzer",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for Aperio ScanScope\u00ae XT System, an automated digital pathology imaging system for semi-quantitative HER2 analysis in breast cancer tissue using immunohistochemistry.",
    "Indications for Use Summary": "Intended as an aid for pathologists in display, detection, counting and classification of tissues and cells, and for semi-quantitative measurement of HER2/neu in breast cancer tissue as an accessory to Dako HercepTest\u2122, supporting assessment for HERCEPTIN\u00ae treatment consideration.",
    "fda_folder": "Hematology"
}